RMTI

Rockwell Medical Inc

RMTI, USA

Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. Its hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics, including dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

https://www.rockwellmed.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
RMTI
stock
RMTI

Rockwell Medical stock jumps after positive preliminary Q4 results By Investing.com Investing.com Australia

Read more →
RMTI
stock
RMTI

Why Is Rockwell Medical Gaining Tuesday? - Rockwell Medical (NASDAQ:RMTI) Benzinga

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$3.75

Analyst Picks

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.92

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-4.74 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-3.05 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-9.64 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

High

0.55

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 21.68% of the total shares of Rockwell Medical Inc

1.

Armistice Capital, LLC

(6.243%)

since

2025/06/30

2.

Vanguard Group Inc

(3.501%)

since

2025/06/30

3.

Vanguard Total Stock Mkt Idx Inv

(2.3119%)

since

2025/07/31

4.

Renaissance Technologies Corp

(1.5735%)

since

2025/06/30

5.

Geode Capital Management, LLC

(0.9313%)

since

2025/06/30

6.

GlobeFlex Capital, L.P.

(0.9063%)

since

2025/06/30

7.

Vanguard Institutional Extnd Mkt Idx Tr

(0.7194%)

since

2025/07/31

8.

BlackRock Inc

(0.6498%)

since

2025/06/30

9.

Marshall Wace Asset Management Ltd

(0.5047%)

since

2025/06/30

10.

Fidelity Extended Market Index

(0.4555%)

since

2025/07/31

11.

Ameriprise Financial Inc

(0.4307%)

since

2025/06/30

12.

State Street Corp

(0.2931%)

since

2025/06/30

13.

HighTower Advisors, LLC

(0.2716%)

since

2025/06/30

14.

Perkins Capital Management Inc

(0.2089%)

since

2025/06/30

15.

Extended Equity Market Fund K

(0.2083%)

since

2025/06/30

16.

iShares Micro-Cap ETF

(0.204%)

since

2025/08/31

17.

Northern Trust Corp

(0.1841%)

since

2025/06/30

18.

Corsair Capital Management LLC

(0.1597%)

since

2025/06/30

19.

Squarepoint Ops LLC

(0.1544%)

since

2025/06/30

20.

Fidelity Total Market Index

(0.1529%)

since

2025/07/31

21.

Panagora Asset Management Inc

(0.1406%)

since

2025/06/30

22.

WEALTHTRUST AXIOM LLC

(0.138%)

since

2025/06/30

23.

LPL Financial Corp

(0.1233%)

since

2025/06/30

24.

Fidelity Series Total Market Index

(0.1155%)

since

2025/07/31

25.

Regions Financial Corp

(0.101%)

since

2025/06/30

26.

NT Ext Equity Mkt Idx Fd - L

(0.101%)

since

2025/06/30

27.

Northern Trust Extended Eq Market Idx

(0.101%)

since

2025/06/30

28.

Spartan Extended Market Index Pool F

(0.1001%)

since

2025/07/31

29.

Richmond Brothers Inc

(0.0946%)

since

2025/06/30

30.

NT Ext Equity Mkt Idx Fd - NL

(0.076%)

since

2025/06/30

31.

Vanguard Instl Ttl Stk Mkt Idx InstlPls

(0.075%)

since

2025/07/31

32.

Vanguard Instl Ttl Stck Mkt Idx Tr

(0.075%)

since

2024/12/31

33.

Beacon Financial Advisors, LLC

(0.0716%)

since

2025/06/30

34.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.059%)

since

2025/06/30

35.

Spartan Total Market Index Pool G

(0.0562%)

since

2025/07/31

36.

Perkins Discovery

(0.0528%)

since

2025/06/30

37.

Fidelity Nasdaq Composite Index

(0.0505%)

since

2025/07/31

38.

Vanguard U.S. Eq Idx £ Acc

(0.0307%)

since

2025/07/31

39.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0285%)

since

2025/06/30

40.

Extended Equity Market Fund M

(0.0262%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.045

Latest Release

Date

2025-09-30

EPS Actual

-0.05

EPS Estimate

-0.05

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(1.5)
Quality
Low Quality Business(2)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.